Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Acarbose biosynthesis patent application claims us?

See the DrugPatentWatch profile for Acarbose

The patent application for acarbose biosynthesis by Bayer AG, filed in the United States, outlines methods for producing the drug. The claims specifically address enzymatic processes and the use of engineered microorganisms for acarbose synthesis [1].

How does this patent application propose to make acarbose?


The patent application details a method for producing acarbose using a transglucosidase enzyme, such as one derived from Aspergillus species. This enzyme is used to convert starch or dextrins into acarbose. The process also involves the use of genetically modified microorganisms, like Escherichia coli, that have been engineered to express these enzymes, facilitating more efficient biosynthesis [1].

What are the key enzymes and organisms mentioned in the patent?


The patent application highlights the use of transglucosidases, particularly from Aspergillus niger or similar fungi, for their ability to catalyze the formation of acarbose from oligosaccharides. It also specifies the use of recombinant DNA technology to express these enzymes in host organisms, such as E. coli [1].

When was this patent application filed and what is its current status?


The patent application was filed in the United States on December 22, 2000, and published as US 2002/0072089 A1 on June 13, 2002. The status of this application and any subsequent granted patents can be tracked through patent databases [1]. For detailed information on patent expiry and exclusivity, resources like DrugPatentWatch.com can provide up-to-date details [2].

What are the commercial implications of patenting acarbose biosynthesis?


Patenting specific biosynthesis methods aims to protect the intellectual property involved in producing acarbose. This can provide a competitive advantage by granting exclusive rights to the patent holder, potentially influencing the market entry of generic versions or alternative production methods [2].

Are there other patents related to acarbose production?


The field of acarbose production has seen various patents covering different aspects, including different production strains, purification methods, and specific enzymatic pathways. DrugPatentWatch.com tracks these patents, offering insights into the broader patent landscape for acarbose [2].

How does acarbose work in the body?


Acarbose is an alpha-glucosidase inhibitor. It works by slowing down the digestion of complex carbohydrates into simple sugars (glucose) in the small intestine. This leads to a more gradual absorption of glucose into the bloodstream after meals, helping to manage blood sugar levels in individuals with type 2 diabetes [3].

What are the potential risks or side effects of acarbose?


Common side effects of acarbose include gastrointestinal issues such as gas, bloating, diarrhea, and abdominal pain. These occur because undigested carbohydrates reach the large intestine, where they are fermented by bacteria. In rare cases, liver enzyme elevations have been reported [3].

What are the alternatives to acarbose for managing type 2 diabetes?


Besides acarbose, numerous other classes of medications are available for type 2 diabetes management. These include metformin, sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, GLP-1 receptor agonists, and insulin, among others. The choice of medication depends on individual patient factors, including blood sugar levels, other health conditions, and potential side effects [3].

What is the typical pricing for acarbose?


The pricing for acarbose can vary depending on the manufacturer, dosage, and whether it is a brand-name or generic product. Generic versions of acarbose are generally more affordable. Insurance coverage also plays a significant role in out-of-pocket costs [3].

Who are the major manufacturers of acarbose?


While Bayer AG developed the original acarbose product (Precose), many generic manufacturers now produce acarbose. Companies such as Aurobindo Pharma, Cipla, and Teva Pharmaceuticals are among those that offer generic acarbose [3].

Sources:
[1] https://patents.google.com/patent/US20020072089A1/en
[2] https://drugpatentwatch.com/
[3] https://www.drugs.com/acarbose.html



Other Questions About Acarbose :

Acarbose? Acarbose? Acarbose? Acarbose biosynthetic gene cluster us patent? Acarbose? Acarbose?